Access cutting-edge prader-willi syndrome treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Palo Alto location
Access prader-willi syndrome specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prader-willi syndrome treatment provided free
Check if you qualify for this prader-willi syndrome clinical trial in Palo Alto, CA
No-Cost Study Care
Local to Palo Alto
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this clinical trial is to learn if ARD-101 works to treat hyperphagia-related behavior in patients with Prader-Willi syndrome (PWS) when used in a long term setting. It will also teach us about the safety of ARD-101. The main questions it aims to answer are: What medical problems do participants have when taking ARD-101 in a long term setting Does ARD-101 improve the total score of the HQCT-9 (hyperphagia questionnaire for clinical trials, 9 questions)? Eligible participants will
Sponsor: Aardvark Therapeutics, Inc.
Yes, this clinical trial (NCT07197034) has an active research site in Palo Alto, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for prader-willi syndrome treatment options in Palo Alto, CA, this clinical trial (NCT07197034) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prader-willi syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all prader-willi syndrome clinical trials near you to find additional studies recruiting in your area.
See all alzheimers disease clinical trials recruiting in Palo Alto — not just this study.
Browse Alzheimers Disease Trials in Palo Alto →